ANI Pharmaceuticals | ANIP - Выручка от реализации





Продажи Изменить Дата
AbbVie USD 15B 1.62B 2026-03
ANI Pharmaceuticals USD 237.5M 9.56M 2026-03
Assertio Holdings USD 29.2M 1.92M 2024-09
Aurora Cannabis CAD 94.19M 3.82M 2025-12
Canopy Growth CAD 74.54M 7.86M 2025-12
Eli Lilly USD 19.8B 500M 2026-03
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novartis USD 13.11B 750M 2026-03
Perrigo USD 969M 141M 2026-03
Sun Pharmaceuticals INR 145.86B 2.13B 2026-03
Teva Pharmaceutical Industries USD 11.77B 2.86B 2026-03